125 related articles for article (PubMed ID: 38856819)
1. Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010-2021).
Alatoom A; Alattas M; Alraddadi B; Moubareck CA; Hassanien A; Jamal W; Kurdi A; Mohamed N; Senok A; Somily AM; Ziglam H
J Epidemiol Glob Health; 2024 Jun; ():. PubMed ID: 38856819
[TBL] [Abstract][Full Text] [Related]
2. Systematic thematic review of e-health research in the Gulf Cooperation Council (Arabian Gulf): Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates.
Weber AS; Turjoman R; Shaheen Y; Al Sayyed F; Hwang MJ; Malick F
J Telemed Telecare; 2017 May; 23(4):452-459. PubMed ID: 27236702
[TBL] [Abstract][Full Text] [Related]
3. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021.
Lee YL; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106867. PubMed ID: 37244423
[TBL] [Abstract][Full Text] [Related]
5.
Santerre Henriksen A; Jeannot K; Oliver A; Perry JD; Pletz MW; Stefani S; Morrissey I; Longshaw C;
Microbiol Spectr; 2024 Apr; 12(4):e0383623. PubMed ID: 38483164
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Oie S; Fukui Y; Yamamoto M; Masuda Y; Kamiya A
BMC Infect Dis; 2009 Aug; 9():123. PubMed ID: 19664245
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
Qader GM; Jarjees KK; Jarjees RK
J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
[No Abstract] [Full Text] [Related]
8. Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019.
Gales AC; Stone G; Sahm DF; Wise MG; Utt E
J Antimicrob Chemother; 2023 Jul; 78(7):1606-1615. PubMed ID: 37161662
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
10. Genomic Characterization of Carbapenem-Non-susceptible
Doumith M; Alhassinah S; Alswaji A; Alzayer M; Alrashidi E; Okdah L; Aljohani S; ; Balkhy HH; Alghoribi MF
Front Microbiol; 2021; 12():765113. PubMed ID: 35069471
[TBL] [Abstract][Full Text] [Related]
11. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
[TBL] [Abstract][Full Text] [Related]
12. Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa - Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020.
Lob SH; Estabrook MA; DeRyke CA; Alekseeva I; Siddiqui F; Young K; Motyl MR; Sahm DF
Int J Infect Dis; 2022 Dec; 125():250-257. PubMed ID: 36244599
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).
AlYousef A; AlGhareeb S; Al Wakeel J; Al-Ghamdi SM; Bieber BA; Hassan M; Al Maimani Y; Alkandari N; Ahmed HZ; Fawzy A; Pisoni RL;
Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S42-50. PubMed ID: 27991478
[TBL] [Abstract][Full Text] [Related]
14. Urinary tract infection by
Jiménez-Guerra G; Heras-Cañas V; Gutiérrez-Soto M; Del Pilar Aznarte-Padial M; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
J Med Microbiol; 2018 Jun; 67(6):790-797. PubMed ID: 29693543
[No Abstract] [Full Text] [Related]
15. Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
Sader HS; Castanheira M; Duncan LR; Mendes RE
Int J Infect Dis; 2021 Dec; 113():279-281. PubMed ID: 34670144
[TBL] [Abstract][Full Text] [Related]
16. Ecological study of breast cancer incidence among nationals and nonnationals in the Gulf Cooperation Council countries.
Chaabna K; Ladumor H; Cheema S
East Mediterr Health J; 2023 Jan; 29(1):40-48. PubMed ID: 36710613
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of
Alfouzan W; Dhar R; Mohsin J; Khamis F; Mokaddas E; Abdullah A; Mustafa AS; Otero A; Wanis P; Matar SH; Khalil S; Alekseeva I; Young K
JAC Antimicrob Resist; 2022 Apr; 4(2):dlac035. PubMed ID: 35465239
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.
Weber C; Schultze T; Göttig S; Kessel J; Schröder A; Tietgen M; Besier S; Burbach T; Häussler S; Wichelhaus TA; Hack D; Kempf VAJ; Hogardt M
Microbiol Spectr; 2022 Oct; 10(5):e0169722. PubMed ID: 36190424
[TBL] [Abstract][Full Text] [Related]
19. Evaluated gene expressions of Metallo beta lactamase genes GIM and , VIM, SPM in Pseudomonas aeruginosa clinical isolates.
Ali MG; Almoneim ZA; Kareem SM
Mol Biol Rep; 2023 Dec; 50(12):10111-10120. PubMed ID: 37917414
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers.
Zowawi HM; Sartor AL; Sidjabat HE; Balkhy HH; Walsh TR; Al Johani SM; AlJindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Johani K; Paterson DL
J Clin Microbiol; 2015 Mar; 53(3):896-903. PubMed ID: 25568439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
